Meet Our Scientific Advisory Board.

Our SAB thought leaders provide an in-depth expertise in clinical development and global registration strategies for novel anti-epileptic drugs. Their insights will be invaluable as Marinus approaches key pipeline milestones.

Aatif Husain, M.D.

Professor of Neurology and Division Chief of Epilepsy, Sleep, and Clinical Neurophysiology at the Duke University School of Medicine, is a world-renowned expert in clinical neurophysiology, with experience serving as president of the American Clinical Neurophysiology Society, treasurer of the International Federation of Clinical Neurophysiology. Through his research Dr. Husain has been highly influential in the developing treatments for seizures, with landmark studies on the treatment of refractory seizures and non-convulsive status epilepticus. Amongst the more than 100 publications and nine books he has authored, he is also the editor-in-chief of the Journal of Clinical Neurophysiology.